Equibles does not estimate personal net worth.
Get an email with a short summary when Oruka Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ORKA alertsJoe Gonzalez has spoken on 1 earnings call across 1 company, most recently for Oruka Therapeutics, Inc. on April 30, 2026. Oruka Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Oruka Therapeutics, Inc. includes Lawrence Klein (CEO and Board Member), Thomas A. Keuer (CEO), Samarth Kulkarni (Chairman and Board Member) and 7 others.
“The results we will be reviewing today are 16-week interim data from EverlastA, which is a double-blind, placebo-controlled phase 2 study of ORCA001 in moderate-to-severe psoriasis.”
Transcript header (unverified)
Biotechnology · Healthcare
